Informations bibliographiques
Ligne directriceWHO consolidated guidelines for the management of common childhood illness: management of sickle-cell disease in children and adolescents
Année de publication2026
Institution émettriceWorld Health Organization
Recommandation
Nouvelle
In children and adolescents (aged 0–19 years) with sickle-cell disease (SCD), experiencing acute painful crises, the use of non-steroidal anti-inflammatory drugs (NSAIDs) is suggested for initial pain management.
Recommandé en faveur
Conditionnelle
Certitude des données probantes
Très faible